Table 4.
Treatment-related adverse effects (n (%)).
| Adverse effects | No. of patients | Total | |||
|---|---|---|---|---|---|
| Grade 1 | Grade 2 | Grade 3 | Grade 4 | ||
| Vomiting and nausea | 3 (30%) | 1 (10%) | 0 | 0 | 4 (40%) |
| Granulocytopenia | 4 (40%) | 1 (10%) | 1 (10%) | 0 | 6 (60%) |
| Leukopenia | 5 (50%) | 2 (20%) | 1 (10%) | 0 | 8 (80%) |
| Thrombocytopenia | 4 (40%) | 1 (10%) | 0 | 0 | 5 (50%) |
| Hypertension | 6 (60%) | 1 (10%) | 1 (10%) | 0 | 8 (80%) |
| Proteinuria | 2 (20%) | 1 (10%) | 0 | 0 | 3 (30%) |
| Fatigue | 5 (50%) | 2 (20%) | 0 | 0 | 7 (70%) |
| Oral mucositis | 4 (40%) | 1 (10%) | 0 | 0 | 5 (50%) |
| Hand-foot syndrome | 3 (30%) | 1 (10%) | 0 | 0 | 4 (40%) |